This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Networking Opportunities

Connections. Connections. Connections

Explore and evaluate new market opportunities worldwide ... Stay one-step ahead of the competitors

NEED HELP GETTING STARTED?


Who attended in 2019
Who attended in 2019

Pharma/Biopharma/Biotech:

  • Engineers/ Scientists/ Researchers/ Project leaders/ VPs/ Heads/ Director/ Manufacturing/ Quality/ QA/ AC / Professors in Bioprocess development, Cellular Therapy, Therapeutics, Pharmacology, Quality Control, Biotherapeutics, Cell Engineering, Regulatory affairs...

Vendor/Consulting:

  • Investment Community, Solution Providers

Academia & Research Organizations:

  • Scientists/Professors/Researchers/Project leaders
They received
They received

The program has been designed for all size pharma/biotech companies and investors seeking:

  • To explore new business opportunities and analyse competitors/partners business cases
  • To hear from organisations that have achieved positive outcomes on the market
  • To learn how to develop a strong cell therapy manufacturing strategy to align with your business objectives
  • To learn what is on the horizon in terms of cell therapy manufacturing
  • 为了满足志同道合的商业人士,分享knowledge and build professional networks.
Benefits of attending
Benefits of attending
  • Grow your professional network
  • Build your knowledge base
    • Learn new things in your field and outside of your field
  • Expand your resources
  • Present your work to others
  • Present your company
  • And many more

Have a question regarding participation at 2019 event?

Delegate Breakdown

100+
Major players attended last year. Let's make this event bigger and better
50:50
Buyers vs. Vendors - Pretty impressive!
60+
Companies came in 2019 - Were you one of them?